RHEUM || Expert Analysis

Amgen’s termination of brodalumab stuns psoriasis world

Posted on: 25/06/2015 - 14:06

VANCOUVER, B.C. – Amgen’s recent announcement that it is pulling the plug on further development of the investigational interleukin-17 receptor A inhibitor brodalumab was the red hot topic among...

Field of Interest: Rheumatology

Type: News Item

Amgen’s termination of brodalumab stuns psoriasis world

Posted on: 25/06/2015 - 14:06

Field of Interest: Dermatology

Type: News Item

Amgen’s termination of brodalumab stuns psoriasis world

Posted on: 25/06/2015 - 14:06

Field of Interest: Rheumatology

Type: News Item

Amgen’s termination of brodalumab stuns psoriasis world

Posted on: 25/06/2015 - 14:06

Field of Interest: Dermatology

Type: News Item

OARSI: Set concrete walking goals in knee OA

Posted on: 02/06/2015 - 12:55

SEATTLE – The pain of knee osteoarthritis is not exacerbated by regular exercise such as walking and may actually be relieved by it, according to several findings presented at the World Congress on...

Field of Interest: Rheumatology

Type: News Item

Microbiome research is decades away from benefiting human health

Posted on: 10/03/2015 - 14:20

MAUI, HAWAII – Don’t look for findings about the human microbiome to have any imminent impact on health, said rheumatologist Peter Lipsky. The hu... More »

Field of Interest: Rheumatology

Type: News Item

Vasculitis patients need up-front protection from steroid side effects

Posted on: 09/03/2015 - 21:19

MAUI, HAWAII – When vasculitis patients are started on corticosteroids, they should also be started on treatments to protect them from the adverse e... More »

Field of Interest: Rheumatology

Type: News Item

Acute anterior uveitis? Consider axial spondyloarthritis

Posted on: 06/03/2015 - 16:09

SNOWMASS, COLO. – Ankylosing spondylitis, far and away, is the most common systemic disease in North America associated with uveitis, Dr. James T. R... More »

Field of Interest: Rheumatology

Type: News Item

New psoriasis drugs offer treatment advantages

Posted on: 27/02/2015 - 19:20

MIAMI BEACH – Two of the newest treatments available for psoriasis – apremilast and secukinumab – are true “game-changers,” according to Dr.... More »

Field of Interest: Dermatology

Type: News Item

What’s new with methotrexate for rheumatoid arthritis

Posted on: 24/02/2015 - 17:45

SNOWMASS, COLO. – Can an old rheumatoid arthritis drug – like an old dog – learn new tricks? When that drug is methotrexate, the answer is def... More »

Field of Interest: Rheumatology

Type: News Item

Amgen’s termination of brodalumab stuns psoriasis world

Amgen’s termination of brodalumab stuns psoriasis world

Amgen’s termination of brodalumab stuns psoriasis world

Amgen’s termination of brodalumab stuns psoriasis world

OARSI: Set concrete walking goals in knee OA

Microbiome research is decades away from benefiting human health

Vasculitis patients need up-front protection from steroid side effects

Acute anterior uveitis? Consider axial spondyloarthritis

New psoriasis drugs offer treatment advantages

What’s new with methotrexate for rheumatoid arthritis

Newsletters

Latest Newsletters

You are here

RHEUM || Expert Analysis

Newsletters

Latest Newsletters